Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older

Name: Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older
License: Public Domain

Sanofi Pasteur, a Sanofi Company

ClinicalTrials.gov · Datasets · License: Public Domain

covid-19 (healthy volunteers)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 181596
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.